Press Release: BetterLife Pharma completes C$10M acquisition of LSD derivative owner Transcend Biodyanmics LLC

CANNANNEW REPORT

Transcend owns BOL-148, a non-toxic second-generation LSD-derived molecule that mimics the therapeutic potential of LSD, without the psychedelic effects or hallucinations BetterLife Pharma Inc (… Read More… The post Press Release: BetterLife Pharma completes C$10M acquisition of LSD derivative owner Transcend Biodyanmics LLC first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : Press Release: BetterLife Pharma completes CM acquisition of LSD derivative owner Transcend Biodyanmics LLC

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.